Euclidean Capital LLC
Net buyer this quarter
$440M
7
+$9.04M
8.3%
Holdings
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026 | |||||
 ORIC | $10.7M | 2.44% | 0.95% | Not reported | Q4 2020 |
 TMS | $9.04M | 2.06% | 1.53% | New | Q2 2026 |
 FHTX | $7.68M | 1.75% | 2.68% | Not reported | Q4 2020 |
 PMVP | $3.52M | 0.80% | 4.92% | Not reported | Q4 2020 |
 ALEC | $2.63M | 0.60% | 1.17% | Not reported | Q4 2020 |
 SRZN | $2.28M | 0.52% | 0.75% | Not reported | Q3 2021 |
 TNYA | $751K | 0.17% | 0.45% | Not reported | Q3 2021 |
| Q1 2026 | |||||
| ORIC | $12.5M | 3.20% | 0.96% | Not reported | Q4 2020 |
| FHTX | $7.52M | 1.92% | 2.68% | Not reported | Q4 2020 |
| PMVP | $3.26M | 0.83% | 4.93% | Not reported | Q4 2020 |
| ALEC | $2.81M | 0.72% | 1.18% | Not reported | Q4 2020 |
| SRZN | $2.55M | 0.65% | 0.76% | Not reported | Q3 2021 |
| TNYA | $703K | 0.18% | 0.47% | Not reported | Q3 2021 |
| Q4 2025 | |||||
| FHTX | $8.5M | 2.30% | 2.78% | Not reported | Q4 2020 |
| ORIC | $8.09M | 2.19% | 1.00% | Not reported | Q4 2020 |
| PMVP | $3.28M | 0.89% | 4.93% | Not reported | Q4 2020 |
 SPY | $2.8M | 0.76% | Not reported | Not reported | Q2 2023 |
| RAPT | $2.79M | 0.75% | 0.30% | Not reported | Q4 2020 |
| ALEC | $2.04M | 0.55% | 1.19% | Not reported | Q4 2020 |
| SRZN | $1.98M | 0.54% | 0.90% | Not reported | Q3 2021 |
| TNYA | $723K | 0.20% | 0.47% | Not reported | Q3 2021 |
| Q3 2025 | |||||
| ORIC | $11.9M | 4.99% | 1.02% | Not reported | Q4 2020 |
| FHTX | $7.7M | 3.23% | 2.78% | Not reported | Q4 2020 |
| ALEC | $3.87M | 1.63% | 1.22% | Not reported | Q4 2020 |
| PMVP | $3.68M | 1.55% | 4.96% | Not reported | Q4 2020 |
| SPY | $2.73M | 1.15% | Not reported | Not reported | Q2 2023 |
| RAPT | $2.12M | 0.89% | 0.50% | Not reported | Q4 2020 |
| TNYA | $1.65M | 0.69% | 0.62% | Not reported | Q3 2021 |
| SRZN | $1.13M | 0.47% | 1.02% | Not reported | Q3 2021 |